InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.690
-0.030 (-1.12%)
Apr 1, 2025, 10:43 AM EDT - Market open
InspireMD Market Cap
InspireMD has a market cap or net worth of $79.87 million as of April 1, 2025. Its market cap has increased by 41.86% in one year.
Market Cap
79.87M
Enterprise Value
47.57M
1-Year Change
41.86%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $79.87M, an increase of 45.47%. That is a compound annual growth rate of 2.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 79.90M | 16.47% |
Dec 31, 2024 | 68.60M | 13.20% |
Dec 29, 2023 | 60.60M | 741.67% |
Dec 30, 2022 | 7.20M | -70.49% |
Dec 31, 2021 | 24.40M | 93.65% |
Dec 31, 2020 | 12.60M | 223.08% |
Dec 31, 2019 | 3.90M | -35.00% |
Dec 31, 2018 | 6.00M | 500.00% |
Dec 29, 2017 | 1.00M | -72.22% |
Dec 30, 2016 | 3.60M | -47.83% |
Dec 31, 2015 | 6.90M | -77.45% |
Dec 31, 2014 | 30.60M | -62.08% |
Dec 31, 2013 | 80.70M | 5.08% |
Dec 31, 2012 | 76.80M | -32.93% |
Dec 30, 2011 | 114.50M | 108.56% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |